Half-year report · Q2
7317.TEDINET S100UN3Q
Period2024-04-01 → 2024-09-30
Filed2024-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.9bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥8.4bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥617m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥619m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥619m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥953m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥437m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥796m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥437m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥11.0bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥9.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥9.7bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.8bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.2bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥4.7bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.3bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.3bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.2bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.0bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.4bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥528m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥262m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥414m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥616m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥546m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥34m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥183m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥146m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥37.49 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.03 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.67 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥37.05 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥44.43 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥20.43 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 56.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥77m |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥25m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥152m |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥924m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥265m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥23m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥23m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥9m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥147m |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.8bn |
| jpcrp040300-q2r_E35560-000Medical Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥693m |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E35560-000Safetysystemreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥62m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥763m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 462
| Item | Context | Value | Unit |
|---|---|---|---|
| Other noe | Prior1YTDDuration | 17238000 | JPY |
| Other noe | CurrentYTDDuration | 1685000 | JPY |
| Non operating expenses | Prior1YTDDuration | 35751000 | JPY |
| Non operating expenses | CurrentYTDDuration | 17688000 | JPY |
| Ordinary income | Prior1YTDDuration | 618888000 | JPY |
| Ordinary income | CurrentYTDDuration | 1091294000 | JPY |
| Income before income taxes | Prior1YTDDuration | 618888000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1091294000 | JPY |
| Income taxes current | Prior1YTDDuration | 124741000 | JPY |
| Income taxes current | CurrentYTDDuration | 238430000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 57035000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 56444000 | JPY |
| Income taxes | Prior1YTDDuration | 181776000 | JPY |
| Income taxes | CurrentYTDDuration | 294874000 | JPY |
| Profit loss | Prior1YTDDuration | 437111000 | JPY |
| Profit loss | CurrentYTDDuration | 796419000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 437111000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 796419000 | JPY |
| Profit loss | Prior1YTDDuration | 437111000 | JPY |
| Profit loss | CurrentYTDDuration | 796419000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 464335000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 212004000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 464335000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 212004000 | JPY |
| Comprehensive income | Prior1YTDDuration | 901447000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1008423000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 901447000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1008423000 | JPY |
| Income before income taxes | Prior1YTDDuration | 618888000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1091294000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 162062000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 94874000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 29138000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 27426000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | 6968000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | 967000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -1663000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -3116000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 18513000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 16002000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -4935000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | 18464000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -402508000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 68616000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -168752000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 414736000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 41895000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -82322000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | 145919000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -160585000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |